Amniotic fluid elicits appetitive responses in human newborns: fatty acids and appetitive responses.

In humans, maternal cues guide newborns to the maternal breast, and transitional cues may be present in maternal-fetal fluids. The aim of the present study was to determine the consistent presence of sensorial cues in three maternal-fetal fluids--amniotic fluid, colostrum, and milk--and test the ability of these cues to produce appetitive responses in newborns. In the analytical study, gas chromatography-mass spectrometry (GC-MS) detected eight fatty acids consistently present in the amniotic fluid, colostrum, and milk from 12 healthy volunteers, but we do not find a mammalian pheromone, identified in another mammalian species (rabbits), in another 30 volunteers. In the behavioral study, we explored the ability of amniotic fluid or its fatty acids to produce appetitive responses in 19 human newborns <24 hr after birth. Exposure to swabs impregnated with amniotic fluid or an artificial fatty acid mixture produced a longer duration of facial reactions that suggested appetitive (sucking) movements compared with respective vehicles (i.e., propylene glycol or centrifuged amniotic fluid with a low fatty acid content verified by GC-MS). We conclude that the fatty acids contained in amniotic fluid may constitute a transitional sensorial cue that guides newborns to the maternal breast.

2-Heptanone increases the firing rate of the basal amygdala: role of anterior olfactory epithelial organs.

Wistar rats subjected to physical stress release a urine alarm pheromone (2-heptanone) that produces signs of anxiety and despair in receptor rats not subjected to physical stress. However, unknown are the effects of 2-heptanone on the firing rate of the basal amygdala, a structure that participates in the expression of fear, and the participation of anterior olfactory epithelial organs, namely the septal organ and vomeronasal organ (SO-VNO). We explored the effects of 2-heptanone applied near the nostrils on single-unit extracellular recordings from the basal amygdala in a sham-operated group and rats that underwent removal of the SO-VNO. The firing rate of basal amygdala neurons in the SO-VNO removal group was significantly higher than in the sham-operated group. In both groups, recordings were classified according to the responses to 2-heptanone (i.e., increased firing rate, decreased firing rate, and no response). SO-VNO removal was associated with an increased firing rate in the three types of neurons. A similar number of neurons increased their firing rate during and after 2-heptanone stimulation in both groups, but such an increase in firing rate was longer in the group of rats subjected to SO-VNO removal. The results indicate that the SO-VNO is not essential for the effect of 2-heptanone on the firing rate of basal amygdala neurons. SO-VNO ablation did not block but rather accentuated the response of amygdala neurons to 2-heptanone.

Preventive Action of Sterculic Oil on Metabolic Syndrome Development on a Fructose-Induced Rat Model.

The metabolic syndrome (MS) underlies metabolic disorders considered risk factors for the development of diabetes and cardiovascular diseases, which are major causes of morbidity and mortality in most of the world. Sterculic acid has been proposed as a potential tool for the treatment of MS since it inhibits the activity of the stearoyl-CoA desaturase-1 (SCD1), a central enzyme in lipid metabolism. We analyzed the effect of sterculic oil (SO) co-administration with 30% fructose in drinking water on the development of MS in male Wistar rats. After 8 weeks, 0.4% SO exerted a protective effect from MS development since parameters altered by fructose (blood pressure, insulin resistance, serum glucose and triglycerides, steatosis, and adiposity) were similar to those of control rats.